Biotech IPOs Lead 2026 US Market While AI Cools

Biotech initial public offerings are taking the lead in the United States stock market for 2026, catching many analysts by surprise. These medical and scientific firms are drawing massive attention, currently overshadowing major artificial intelligence companies like Anthropic.

Prediction markets are reacting strongly to this shift in investor interest. Betting contracts give Anthropic a 63.5 percent chance of completing its own public offering before December 31, 2026, reflecting solid expectations despite the current biotech craze.

Traders and market watchers should keep an eye on sector rotations as capital moves between technology and healthcare. Shifts in traditional venture funding and public listings often spill over into broader risk assets, including digital currencies and broader market sentiment.